(Q40667655)

22 September 2017

1 reference

title

Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A. (English)

1 reference

cytophagic histiocytic panniculitis

22 September 2017

main subject

1 reference

1 reference

Ostrov BE

1

1 reference

22 September 2017

Athreya BH

series ordinal

2

1 reference

22 September 2017

Eichenfield AH

series ordinal

3

1 reference

22 September 2017

Goldsmith DP

series ordinal

4

1 reference

22 September 2017

publication date

1 June 1996

1 reference

Seminars in Arthritis and Rheumatism

22 September 2017

published in

1 reference

22 September 2017

volume

25

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

404-413

1 reference

Cytophagic histiocytic panniculitis with fever, cytopenia, liver failure, and terminal hemorrhagic diathesis

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Histiocytic cytophagic panniculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

1 reference

7 January 2021

Cytophagic histiocytic panniculitis is not always fatal

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Panniculitis and fever in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Treatment of cytophagic panniculitis with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Successful treatment of weber-christian disease by cyclosporin a

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Haemophagocytic syndrome treated with cyclosporin A: a T cell disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cytophagic histiocytic panniculitis. Systemic histiocytosis presenting as chronic, nonhealing, ulcerative skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Acute, generalized panniculitis with amylase and lipase in skin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Histiocytic cytophagic panniculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cytophagic histiocytic panniculitis: a report of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cytophagic panniculitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Detection of circulating tumour necrosis factor in systemic histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Treatment of Weber-Christian panniculitis with cyclosporine A

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Panniculitis. New findings in the 'third compartment'.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Systemic Lupus Erythematosus Presenting as Panniculitis (Lupus Profundus)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Panniculitis associated with cutaneous T-cell lymphoma and cytophagocytic histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

1 reference

7 January 2021

Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo. Norwegian Arthritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cyclosporin A in adult-onset cyclic neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Renal function and blood pressure in patients receiving long-term, low-dose cyclosporine therapy for idiopathic autoimmune uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Tumor necrosis, cachexia, shock, and inflammation: a common mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cytophagic histiocytic panniculitis evolving into total lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Histiocytic cytophagic panniculitis: molecular evidence for a clonal T-cell disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

Cyclosporine A in a case of refractory severe aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-0172%2896%2980005-9

7 January 2021

10.1016/S0049-0172(96)80005-9

Identifiers

DOI

1 reference

22 September 2017

1 reference